Osteogenic potential of human adipose derived stem cells (hASCs) seeded on titanium trabecular spinal cages.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 10 2020
26 10 2020
Historique:
received:
30
05
2020
accepted:
07
10
2020
entrez:
27
10
2020
pubmed:
28
10
2020
medline:
22
12
2020
Statut:
epublish
Résumé
Spine degenerative conditions are becoming increasingly prevalent, affecting about 5.7% of the population in Europe, resulting in a significant reduction of life's quality. Up to now, many materials have been used in manufacturing cage implants, used as graft substitutes, to achieve immediate and long-term spinal fixation. Particularly, titanium and its alloys are emerging as valuable candidates to develop new types of cages. The aim of this in vitro study was to evaluate the adhesion, proliferation and osteogenic differentiation of adipose derived mesenchymal stem cells (ASCs) seeded on trabecular titanium cages. ASCs adhered, proliferated and produced an abundant extracellular matrix during the 3 weeks of culture. In the presence of osteogenic medium, ASCs differentiated into osteoblast-like cells: the expression of typical bone genes, as well as the alkaline phosphatase activity, was statistically higher than in controls. Furthermore, the dispersive spectrometry microanalysis showed a marked increase of calcium level in cells grown in osteogenic medium. Plus, our preliminary data about osteoinduction suggest that this titanium implant has the potential to induce the ASCs to produce a secretome able to trigger a shift in the ASCs phenotype, possibly towards the osteogenic differentiation, as illustrated by the qRT-PCR and ALP biochemical assay results. The trabecular porous organization of these cages is rather similar to the cancellous bone structure, thus allowing the bone matrix to colonize it efficiently; for these reasons we can conclude that the architecture of this cage may play a role in modulating the osteoinductive capabilities of the implant, thus encouraging its engagement in in vivo studies for the treatment of spinal deformities and diseases.
Identifiants
pubmed: 33106587
doi: 10.1038/s41598-020-75385-y
pii: 10.1038/s41598-020-75385-y
pmc: PMC7589498
doi:
Substances chimiques
Titanium
D1JT611TNE
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
18284Références
J Neurosurg Spine. 2007 May;6(5):496-511
pubmed: 17542522
Eur Spine J. 2000 Oct;9(5):410-6
pubmed: 11057535
Orthopedics. 1988 Jun;11(6):931-4
pubmed: 3387340
Int J Biomater. 2017;2017:5093063
pubmed: 28814954
Orthop Surg. 2016 Aug;8(3):278-84
pubmed: 27627709
J Biomed Mater Res A. 2010 Sep 1;94(3):790-9
pubmed: 20336739
Int J Mol Sci. 2017 Dec 13;18(12):
pubmed: 29236047
Eur Spine J. 2001 Oct;10 Suppl 2:S96-101
pubmed: 11716023
BMC Musculoskelet Disord. 2015 Apr 25;16:99
pubmed: 25907826
World Neurosurg. 2018 Mar;111:1-5
pubmed: 29223522
Eur J Orthop Surg Traumatol. 2016 Jan;26(1):1-7
pubmed: 26050235
Biol Cell. 2010 May 26;102(8):457-67
pubmed: 20415666
J Neurosurg. 2000 Oct;93(2 Suppl):222-6
pubmed: 11012052
Eur Cell Mater. 2011 May 15;21:407-29; discussion 429
pubmed: 21604242
J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4 Suppl):15-24
pubmed: 26652487
J Neurosurg Spine. 2017 Apr;26(4):435-440
pubmed: 28059683
PLoS One. 2014 Sep 08;9(9):e107001
pubmed: 25198551
J Biomed Mater Res A. 2014 Jul;102(7):2061-71
pubmed: 23894030
Spine (Phila Pa 1976). 2007 Oct 1;32(21):2310-7
pubmed: 17906571
Eur Spine J. 2009 Apr;18(4):449-64
pubmed: 19152011
J Biomed Mater Res A. 2006 Jun 15;77(4):747-62
pubmed: 16557498
Spine (Phila Pa 1976). 2003 Feb 15;28(4):317-23
pubmed: 12590203